EVALUATION OF A BASAL BOLUS INSULIN PROTOCOL FOR CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION

被引：0
|
作者：
Greene, Maureen [1 ]
机构：
[1] Wheaton Franciscan Healthcare St Joseph, Milwaukee, WI USA
来源：
CRITICAL CARE MEDICINE | 2014年 / 42卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
334
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of 6-month treatment with insulin detemir in type 1 diabetic patients on a basal-bolus regimen
    Roberts, A
    Standl, E
    Bayer, T
    Munksgaard, E
    Lang, H
    DIABETOLOGIA, 2001, 44 : A207 - A207
  • [22] Efficacy and Safety of a New Basal Insulin with a Bolus Boost (IDegAsp) Used Once Daily in Combination with Insulin Aspart (IAsp) in People with Type 1 Diabetes
    Hirsch, Irl B.
    Franek, Edward
    Courreges, Jean-Pierre
    Mersebach, Henriette
    Dykiel, Patrik
    Bode, Bruce W.
    DIABETES, 2011, 60 : A292 - A292
  • [23] Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal-bolus therapy)
    Kawaguchi, Yuji
    Sawa, Jun
    Hamai, Chie
    Nishimura, Yuri
    Kumeda, Yasuro
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1527 - 1536
  • [24] The Efficacy and Safety of Basal Insulin in Diabetes Mellitus: A Systematic Review
    Li, Sheyu
    Feng, Donglai
    Tian, Haoming
    DIABETES, 2011, 60 : A256 - A256
  • [25] A Protocol Specifying Basal/Bolus Subcutaneous Insulin Therapy for Glycemic Control in Cardiac Surgery Patients
    Terry, Peter
    Siu, Sarah
    Salak, Kathleen
    Lee, Daniel
    Tak, Vinay
    Kamran, Haroon
    Ko, Wilson
    DIABETES, 2010, 59 : A575 - A575
  • [26] Efficacy and safety of an insulin infusion protocol in a surgical ICU
    Taylor, BE
    Schallom, ME
    Sona, CS
    Buchman, TG
    Boyle, WA
    Mazuski, JE
    Schuerer, DE
    Thomas, JM
    Kaiser, C
    Huey, WY
    Ward, MR
    Zack, JE
    Coopersmith, CM
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 1 - 9
  • [27] A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed
    Lichtenegger, Katharina M.
    Aberer, Felix
    Tuca, Alexandru C.
    Donsa, Klaus
    Holl, Bernhard
    Schaupp, Lukas
    Plank, Johannes
    Beck, Peter
    Fruhwald, Friedrich
    Pieber, Thomas R.
    Mader, Julia K.
    DIABETES, 2019, 68
  • [28] Efficacy and Safety in Patients Switched to an Insulin Glargine Plus Rapid-Acting Analog Basal-Bolus Regimen: The GLAD Study
    Oroszlan, Tamas
    DIABETES, 2011, 60 : A604 - A605
  • [29] Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
    Vellanki, Priyathama
    Cardona, Saumeth
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Pasquel, Francisco J.
    Davis, Georgia M.
    Fayfman, Maya
    Migdal, Alexandra
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES CARE, 2022, 45 (10) : 2217 - 2223
  • [30] Efficacy and safety of post-meal insulin glulisine (GLU) compared with pre-meal regular human insulin (RHI) in a basal-bolus regimen with insulin glargine
    Garg, S
    Rosenstock, J
    Ways, K
    DIABETES, 2004, 53 : A125 - A125
12345